Ambulatory blood pressure monitoring in clinical practice: A review

American Journal of Medicine

Volumn 128, Issue 1, 2015, Pages 14-20

  Turner, J Rick ^a   Viera, Anthony J ^b   Shimbo, Daichi ^c  

^a IQVIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Department of Medicine   (United States)

Author keywords

Ambulatory blood pressure monitoring; High blood pressure; Masked hypertension; Nocturnal blood pressure; White coat hypertension

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL PRACTICE; HUMAN; MASKED HYPERTENSION; PREDICTION; PRIORITY JOURNAL; RESISTANT HYPERTENSION; REVIEW; WHITE COAT HYPERTENSION; BLOOD PRESSURE; HYPERTENSION;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION;

EID: 84925284552     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.07.021     Document Type: Review

References (54)

1. Horton R. GBD 2010: understanding disease, injury, and risk. Lancet. 2013;380:2053-2054.
2. Das P, Samarasekera U. The story of GBD 2010: A "super-human" effort. Lancet. 2013;380:2067-2070.
3. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2224-2260.
4. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart and stroke statisticse2014 update. A report from the American Heart Association. Circulation. 2014;129:e28-e292.
5. Winter KH, Tuttle LA, Viera AJ. Hypertension. Prim Care. 2013;40: 179-194.
6. Turner JR, Hoofwijk TJ. Clinical trials in new drug development. J Clin Hypertens (Greenwich). 2013;15:306-309.
7. Pickering T, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368-2374.
8. Krakoff LR. Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management. Curr Atheroscler Rep. 2013;15:317.
9. National Institute for Health and Care Excellence. Clinical Guideline 127. Hypertension: clinical management of primary hypertension in adults. August 2011. Available at: http://guidance.nice.org.uk/CG127/Guidance. Accessed June 20, 2014.
10. National Heart Foundation and High Blood Pressure Research Council of Australia Ambulatory Blood Pressure Monitoring Consensus Committee. Ambulatory blood pressure monitoring. Aust Fam Physician. 2011;40:877-880.
11. Campbell NR, Hemmelgarn BR. New recommendations for the use of ambulatory blood pressure monitoring in the diagnosis of hypertension. CMAJ. 2012;184:633-634.
12. Japanese Circulation Society Joint Working Group. Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): digest version. Circ J. 2012;76:508-519.
13. International Society for Chronobiology; American Association of Medical Chronobiology and Chronotherapeutics; Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk; Spanish Society of Atherosclerosis; Romanian Society of Internal Medicine, Hermida RC, Smolensky MH, Ayala DE, Portaluppi F. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Chronobiol Int. 2013;30:355-410.
14. O'Brien E, Parati G, Stergiou G, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731-1768.
15. O'Brien E, Parati G, Stergiou G, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring.Erratum: J Hypertens. 2013;31:2467.
16. Flynn JT, Daniels SR, Hayman LL, et al; on behalf of the American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Update: Ambulatory blood pressure monitoring in children and adolescents: A scientific statement from the American Heart Association. Hypertension. 2014;63:1116-1135.
17. Parati G, Stergiou G, O'Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359-1366.
18. Liu W, Ye H, Tang B, et al. Comparison of 44-hour and fixed 24-hour ambulatory blood pressure monitoring in dialysis patients. J Clin Hypertens (Greenwich). 2014;16:63-69.
19. Ray GM, Nawarskas JJ, Anderson JR. Blood pressure monitoring technique impacts hypertension treatment. J Gen Intern Med. 2012;27: 623-629.
20. Powers BJ, Olsen MK, Smith VA, Woolson RF, Bosworth HB, Oddone EZ. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med. 2011;154: 781-788, W-289-290.
21. O'Brien E, Pickering T, Asmar R, et al; on behalf of the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. International protocol for validation of blood pressure measuring devices in adults. Blood Press Monit. 2002; 7:3-17.
22. O'Brien E, Atkins N, Stergiou G, et al; on behalf of the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. European Society of Hypertension International Protocol for the Validation of Blood Pressure Measuring Devices in Adults. 2010 Revision. Blood Press Monit. 2010;15:23-38.
23. Stergiou G, Karpettas N, Atkins N, O'Brien E. European Society of Hypertension International Protocol for the validation of blood pressure monitors: A critical review of its application and rationale for revision. Blood Press Monit. 2010;15:39-48.
24. O'Brien E. First Thomas Pickering Memorial Lecture: Ambulatory blood pressure measurement is essential for the management of hypertension. J Clin Hypertens (Greenwich). 2012;14:836-847.
25. Giles TD, Black HR, Messerli F, White WB. Ambulatory blood pressure monitoring should be included in the National Health and Nutritional Examination Survey (NHANES). J Am Soc Hypertens. 2012;6:364-366.
26. Campbell P, Ghuman N, Wakefield D, Wolfson L, White WB. Longterm reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly. J Hum Hypertens. 2010;24:749-754.
27. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983;249:2792-2798.
28. Mancia G, Zanchetti A, Agabiti-Rosei E, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatmentinduced regression of left ventricular hypertrophy. Circulation. 1997;95:1464-1470.
29. Mancia G, Zanchetti A, Agabiti-Rosei E, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatmentinduced regression of left ventricular hypertrophy.Erratum: Circulation. 1997;96:1065.
30. Verdecchia P, Angeli F, Cavallini C. Ambulatory blood pressure for cardiovascular risk stratification. Circulation. 2007;115:2091-2093.
31. Verdecchia P, Angeli F. How can we use the results of ambulatory blood pressure monitoring in clinical practice? Hypertension. 2005;46: 25-26.
32. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA. 1988;259:225-228.
33. Franklin SS, Thijs L, Hansen TW, et al. White-coat hypertension: new insights from recent studies. Hypertension. 2013;62:982-987.
34. Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: A modelling study. Lancet. 2011;378:1219-1230.
35. Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: A modelling study.Erratum: Lancet. 2011;378:1218.
36. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens. 2001;14:1263-1269.
37. de la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898-902.
38. White WB, Turner JR, Sica D, et al. Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive Forum held in Bethesda, Maryland, USA, October 10th 2013. J Am Soc Hypertens. 2014;8: 743-757.
39. Peacock J, Diaz KM, Viera AJ, et al. Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens. 2014;28:521-528.
40. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;13:564-572.
41. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104:1385-1392.
42. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: A meta-analysis. J Hypertens. 2007;25:2193-2198.
43. Shimbo D, Newman JD, Schwartz JE. Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: The Masked Hypertension Study. Am J Hypertens. 2012;25:664-671.
44. Krakoff LR. Cost-effectiveness of ambulatory blood pressure: A reanalysis. Hypertension. 2006;47:29-34.
45. Swartz SJ, Srivaths PR, Croix B, Feig DI. Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children. Pediatrics. 2008;122:1177-1181.
46. Wang YC, Koval AM, Nakamura M, et al. Cost-effectiveness of secondary screening modalities for hypertension. Blood Press Monit. 2013;18:1-7.
47. Bloch MJ, Basile JN. New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United States. J Clin Hypertens (Greenwich). 2011;13:785-786.
48. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520.
49. Supplement to 2014 Evidence-based guideline for the management of high blood pressure in adults: report by the panel appointed to the Eighth Joint National Committee (JNC 8). Available at: http://jama.jamanetwork.com/article.aspx?articleid1/41791497#ArticleInformation. Accessed June 1, 2014.
50. [No authors listed] ESH Hypertension Excellence Centres: A new strategy to combat an old foe. Blood Press. 2007;16:276-277.
51. White WB, Kostis JB. Leadership message. American Society of Hypertension-designated centers of excellence: A new initiative. J Clin Hypertens (Greenwich). 2011;13:391-392.
52. James K, Dolan E, O'Brien E. Making ambulatory blood pressure monitoring accessible in pharmacies. Blood Press Monit. 2014;19: 134-139.
53. Hermida RC, Ayala DE, Fernández JR, et al. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int. 2013;30:280-314.
54. Hermida RC, Ayala DE, Mojón A, Fernández JR. Decreasing sleeptime blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58:1165-1173.